| [1] |
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470.
|
| [2] |
Umemura T, Shibata S, Sekiguchi T, et al. Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis[J]. Hepatol Res, 2015, 45(7): 739-744.
|
| [3] |
Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660.
|
| [4] |
Zhang Q, Guo X, Zhao S, et al. Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients[J]. Exp Ther Med, 2016, 11(4): 1348-1354.
|
| [5] |
Burak KW, Meeberg GA, Myers RP, et al. Validation, current use and future directions of the model for end-stage liver disease for liver transplant allocation in Canada[J]. Can J Gastroenterol Hepatol, 2015: 16942.
|
| [6] |
Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more[J]. Curr Opin Organ Transplant, 2016, 21(2): 120-126.
|
| [7] |
Fayad L, Narciso-Schiavon JL, Lazzarotto C, et al. The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis[J]. Ann Hepatol, 2015, 14(1): 83-92.
|
| [8] |
Peng Y, Qi X, Tang S, et al. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(8): 971-980.
|
| [9] |
McPhail MJ, Farne H, Senvar N, et al. Ability of King’s College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: A Meta-analysis[J]. Clin Gastroenterol Hepatol, 2016, 14(4): 516-525，e515.
|
| [10] |
Lai YH, Duan WD, Yu Q, et al. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease[J]. World J Gastroenterol, 2015, 21(20): 6296-6303.
|
| [11] |
Annamalai A, Harada MY, Chen M, et al. Predictors of mortality in the critically ill cirrhotic patient: Is the model for end-stage liver disease enough?[J]. J Am Coll Surg, 2017, 224(3): 276-282.
|
| [12] |
Nagai S, Chau LC, Schilke RE, et al. Effects of allocating livers for transplantation based on model for end-stage liver disease-sodium scores on patient outcomes[J]. Gastroenterology, 2018, 155(5): 1451-1462，e1453.
|
| [13] |
Boin IF, Leonardi MI, Luzo AC, et al. Intraoperative massive transfusion decreases survival after liver transplantation[J]. Transplant Proc, 2008, 40(3): 789-791.
|
| [14] |
Makroo RN, Walia RS, Aneja S, et al. Preoperative predictors of blood component transfusion in living donor liver transplantation[J]. Asian J Transfus Sci, 2013, 7(2): 140-146.
|
| [15] |
Massicotte L, Beaulieu D, Roy JD, et al. MELD score and blood product requirements during liver transplantation: no link[J]. Transplantation, 2009, 87(11): 1689-1694.
|
| [16] |
Jacob M, Copley LP, Lewsey JD, et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland[J]. Liver Transpl, 2004, 10(7): 903-907.
|
| [17] |
Sharma P, Schaubel DE, Goodrich NP, et al. Serum sodium and survival benefit of liver transplantation[J]. Liver Transpl, 2015, 21(3): 308-313.
|
| [18] |
Klein KB, Stafinski TD, Menon D. Predicting survival after liver transplantation based on pre-transplant MELD score: A systematic review of the literature[J]. PLoS One, 2013, 8(12): e80661.
|
| [19] |
余忠山, 江艺, 蔡秋程, 等. MELD评分和CTP分级评估肝移植术后并发症及死亡风险的临床分析[J/CD]. 中华普通外科学文献（电子版）, 2013, 7(6): 466-471.
|
| [20] |
Zhang QK, Wang ML. Value of model for end-stage liver disease-serum sodium scores in predicting complication severity grades after liver transplantation for acute-on-chronic liver failure[J]. Transplant Proc, 2019, 51(3): 833-841.
|
| [21] |
Lim S, Kim EJ, Lee TB, et al. Predictors of postoperative infectious complications in liver transplant recipients: experience of 185 consecutive cases[J]. Korean J Intern Med, 2018, 33(4): 798-806.
|
| [22] |
Foxton MR, Al-Freah MA, Portal AJ, et al. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs[J]. Liver Transpl, 2010, 16(5): 668-677.
|
| [23] |
González Martínez S, Molina Raya A, Becerra Massare A, et al. Liver transplantation in recipients with high model for end-stage liver disease score[J]. Transplant Proc, 2018, 50(2): 595-597.
|
| [24] |
Smith JO, Shiffman ML, Behnke M, et al. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes[J]. Liver Transpl, 2009, 15(3): 273-279.
|
| [25] |
Schlegel A, Linecker M, Kron P, et al. Risk assessment in high- and low-MELD liver transplantation[J]. Am J Transplant, 2017, 17(4): 1050-1063.
|
| [26] |
Wronka KM, Grat M, Stypułkowski J, et al. Liver transplantation outcomes in recipients with high model for end-stage liver disease (MELD) scores: The relevance of MELD scores[J]. Ann Transplant，2017, 22: 251-256.
|
| [27] |
Cheng Y, Wei GQ, Cai QC, et al. Prognostic value of model for end-stage liver disease incorporating with serum sodium score for development of acute kidney injury after liver transplantation[J]. Chin Med J (Engl), 2018, 131(11): 1314-1320.
|
| [28] |
刘东岳, 解曼, 孔心涓, 等. 实体器官移植受者移植术后下消化道并发症流行病学及影响因素[J/CD]. 中华移植杂志(电子版), 2019, 13(1): 71-74.
|
| [29] |
Seehofer D, Eurich D, Veltzke-Schlieker W, et al. Biliary complications after liver transplantation: old problems and new challenges[J]. Am J Transplant, 2013, 13(2): 253-265.
|
| [30] |
Berumen J, Hemming A. Liver retransplantation: How much is too much?[J]. Clin Liver Dis, 2017, 21(2): 435-447.
|
| [31] |
Rana A, Petrowsky H, Kaplan B, et al. Early liver retransplantation in adults[J]. Transpl Int, 2014, 27(2): 141-151.
|
| [32] |
Kim HJ, Larson JJ, Lim YS, et al. Impact of MELD on waitlist outcome of retransplant candidates[J]. Am J Transplant, 2010, 10(12): 2652-2657.
|
| [33] |
Shah JA, Patel MS, Kratz JR, et al. High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation[J]. Ann Hepatol, 2016, 15(6): 888-894.
|
| [34] |
Hong JC, Kaldas FM, Kositamongkol P, et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients: Analysis of a 26-year experience in a single center[J]. Ann Surg, 2011, 254(3): 444-448.
|
| [35] |
Biggins SW, Gralla J, Dodge JL, et al. Survival benefit of repeat liver transplantation in the United States: A serial MELD analysis by hepatitis C status and donor risk index[J]. Am J Transplant, 2014, 14(11): 2588-2594.
|
| [36] |
Al-Saeedi M, Yassein T, Schultze D, et al. Impact of inter-laboratory variability on model of end-stage liver disease (MELD) score calculation[J]. Ann Hepatol, 2016, 15(21): 675-682.
|
| [37] |
Myers RP, Shaheen AA, Aspinall AI, et al. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate[J]. J Hepatol, 2011, 54(3): 462-470.
|